These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 13207636)

  • 1. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB
    Am Rev Tuberc; 1954 Nov; 70(5):852-72. PubMed ID: 13207636
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.
    COHN ML; KOVITZ C; ODA U; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Oct; 70(4):641-64. PubMed ID: 13197742
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
    MIDDLEBROOK G
    Am Rev Tuberc; 1954 Mar; 69(3):471-2. PubMed ID: 13138881
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid susceptibility, catalase activity, and guinea pig virulence of recently isolated cultures of tubercle bacilli.
    WOLINSKY E; SMITH MM; STEENKEN W
    Am Rev Tuberc; 1956 May; 73(5):768-72. PubMed ID: 13313962
    [No Abstract]   [Full Text] [Related]  

  • 5. Attenuation of highly isoniazid-resistant tubercle bacilli.
    HIRANO N; NAKANISHI K; FUKUNAGA K
    Yokohama Med Bull; 1955 Aug; 6(4):196-202. PubMed ID: 13300158
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro.
    COHN ML; ODA U; KOVITZ C; MIDDLEBROOK G
    Am Rev Tuberc; 1954 Sep; 70(3):465-75. PubMed ID: 13189061
    [No Abstract]   [Full Text] [Related]  

  • 7. The virulence of isoniazid resistant tubercle bacilli, recovered from patients during treatment.
    MEISSNER G
    Dis Chest; 1954 Jul; 26(1):15-26. PubMed ID: 13173335
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the virulence of chemoresistant tubercle bacilli. II. Tubercle bacilli which have become resistant to isoniazid in vivo].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 110(6):538-46. PubMed ID: 13159801
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of isoniazid on growing and resting tubercle bacilli.
    SCHAEFER WB
    Am Rev Tuberc; 1954 Jan; 69(1):125-7. PubMed ID: 13114634
    [No Abstract]   [Full Text] [Related]  

  • 10. Virulence of tubercle bacilli recovered from patients treated with isoniazid.
    STEENKEN W; WOLINSKY E
    Am Rev Tuberc; 1953 Oct; 68(4):548-56. PubMed ID: 13104867
    [No Abstract]   [Full Text] [Related]  

  • 11. Some aspects of virulence of isoniazid-resistant tubercle bacilli.
    KANAI K; TAKAHASHI H; KATSUYAMA S; YANAGISAWA K
    Jpn J Med Sci Biol; 1955 Dec; 8(6):413-24. PubMed ID: 13345538
    [No Abstract]   [Full Text] [Related]  

  • 12. Some remarks concerning attenuated isoniazid-resistant strains of tubercle bacilli.
    JENSEN KA
    Acta Pathol Microbiol Scand; 1955; 37(1):71-8. PubMed ID: 14398264
    [No Abstract]   [Full Text] [Related]  

  • 13. Virulence of isoniazid-resistant tubercle bacilli.
    MITCHISON DA
    Am Rev Tuberc; 1954 Apr; 69(4):640-1. PubMed ID: 13148527
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the development of resistance of tubercle bacilli to isoniazid.
    VENNESLAND K
    Trans Annu Meet Natl Tuberc Assoc; 1953; 49():183-91. PubMed ID: 13136314
    [No Abstract]   [Full Text] [Related]  

  • 15. Public health significance of tubercle bacilli resistant to isoniazid.
    WIDELOCK D; PEIZER LR; KLEIN S
    Am J Public Health Nations Health; 1955 Jan; 45(1):79-83. PubMed ID: 13218190
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemotherapeutic agents and their resistance against tubercle bacilli. III. Hemin starch liquid medium for the cultivation of isoniazid-susceptible and resistant tubercle bacilli.
    SHOJI M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):377-90. PubMed ID: 13298725
    [No Abstract]   [Full Text] [Related]  

  • 17. Haeminisoniazid interaction and the effect of haemin in reviving isoniazid-treated tubercle bacilli.
    KNOX R; WOODROFFE RC
    Br J Exp Pathol; 1955 Aug; 36(4):425-31. PubMed ID: 13250119
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression of tuberculous lesions in guinea pigs infected with isoniazid-resistant tubercle bacilli.
    KARLSON AG
    Am Rev Tuberc; 1954 Sep; 70(3):531-2. PubMed ID: 13189071
    [No Abstract]   [Full Text] [Related]  

  • 19. Developments in the laboratory: the growth requirements and pathogenic properties of isoniazid-resistant tubercle bacilli.
    MIDDLEBROOK G; COHN ML; SCHAEFER WB; KOVITZ C
    Trans Annu Meet Natl Tuberc Assoc; 1954; 96(50th Meeting):239-40. PubMed ID: 13216871
    [No Abstract]   [Full Text] [Related]  

  • 20. Revival of tubercle bacilli after prolonged in vitro exposure to isoniazid.
    FISHER MW
    Proc Soc Exp Biol Med; 1954 Apr; 85(4):538-40. PubMed ID: 13167130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.